BEAMER

Behavioral and adherence model for improving quality, health outcomes and cost-effectiveness of healthcare

Summary

Around half of all patients do not take their treatment as prescribed. This ‘non-adherence’ to treatment can have a dramatic impact on patients’ health and quality of life, resulting in avoidable hospitalisations and contributing to an estimated 200 000 deaths annually in the EU.

Currently, we do not fully understand all the factors that influence patients’ decisions regarding their treatments. The BEAMER project aims to add to our understanding of the factors that influence patient adherence across disease areas, and deliver guidance that various stakeholders could use to address patients’ needs and boost adherence.

The project will create a model of the main factors affecting patient adherence to treatment and test it in pilot studies involving 18 000 patients in 6 countries. This will allow the project team to define non-adherence and develop guidance that healthcare stakeholders could transform into tools and solutions to improve adherence. The model will not be disease specific, but it will be possible for users to add disease-specific elements. This will make the model more widely applicable to different groups of patients.

Achievements & News

Participants

  Show participants on map
EFPIA companies
  • Astellas Pharma Europe BV, Leiden, Netherlands
  • Janssen Pharmaceutica Nv, Beerse, Belgium
  • Merck Kommanditgesellschaft Auf Aktien, Darmstadt, Germany
  • Novo Nordisk A/S, Bagsvaerd, Denmark
  • Pfizer Limited, Sandwich, Kent , United Kingdom
  • Servier Affaires Medicales, Suresnes, France
  • Takeda Pharmaceuticals International AG, Glattpark-Opfikon (Zurich), Switzerland
Universities, research organisations, public bodies, non-profit groups
  • Akershus Universitetssykehus Hf, Lorenskog, Norway
  • Echalliance Company Limited By Guarantee, Dublin, Ireland
  • Ethniko Kentro Erevnas Kai Technologikis Anaptyxis, Thermi Thessaloniki, Greece
  • Fundacio Institut Universitari Pera La Recerca A L'Atencio Primaria De Salut Jordi Gol I Gurina, Barcelona, Spain
  • Heinrich-Heine-Universitaet Duesseldorf, Düsseldorf, Germany
  • Klinikum Der Universitaet Zu Koeln, Cologne, Germany
  • Servicio Madrileno De Salud, Madrid, Spain
  • Stichting Katholieke Universiteit Brabant, Tilburg, Netherlands
  • Udg Alliance, Lausanne, Switzerland
  • Universidad Politecnica De Madrid, Madrid, Spain
  • Universidade Do Porto, Porto, Portugal
  • Universitetet I Oslo, Oslo, Norway
Small and medium-sized enterprises (SMEs) and mid-sized companies (<€500 m turnover)
  • Empirica Gesellschaft Fur Kommunikations Und Technologieforschung Mbh, Bonn, Germany
  • Innovation Sprint, Bruxelles, Belgium
  • Medida - Servicos Em Medicina, Educacao, Investigacao, Desenvolvimento E Avaliacao, Porto, Portugal
  • Mysphera SL, Paterna, Spain
  • Open Evidence, Barcelona, Spain
Patient organisations
  • Associacao Protectora Dos Diabeticos De Portugal, Lisboa, Portugal
  • Fondazione Italiana Sclerosi Multipla Fism Onlus, Genoa, Italy
  • Stichting United Parent Projects Muscular Dystrophy, Veenendaal, Netherlands
Associated partners
  • Link2trials BV, Hilversum, Netherlands
Third parties
  • Fundacion Para La Investigacion Biomedica Hospital Infantil Universitario Nino Jesus, Madrid, Spain
  • Fundación Para La Investigación E Innovación Biosanitaria De Atención Primaria, Madrid, Spain

Participants
NameIHI funding in €
Akershus Universitetssykehus Hf516 875
Associacao Protectora Dos Diabeticos De Portugal239 063
Echalliance Company Limited By Guarantee202 500
Empirica Gesellschaft Fur Kommunikations Und Technologieforschung Mbh346 250
Ethniko Kentro Erevnas Kai Technologikis Anaptyxis360 938
Fondazione Italiana Sclerosi Multipla Fism Onlus220 625
Fundacio Institut Universitari Pera La Recerca A L'Atencio Primaria De Salut Jordi Gol I Gurina40 938
Heinrich-Heine-Universitaet Duesseldorf241 563
Innovation Sprint343 750
Klinikum Der Universitaet Zu Koeln25 938
Medida - Servicos Em Medicina, Educacao, Investigacao, Desenvolvimento E Avaliacao176 250
Mysphera SL231 750
Open Evidence584 500
Servicio Madrileno De Salud64 688
Stichting Katholieke Universiteit Brabant422 813
Stichting United Parent Projects Muscular Dystrophy266 406
Udg Alliance225 000
Universidad Politecnica De Madrid386 875
Universidade Do Porto409 998
Universitetet I Oslo467 813
 
Third parties
NameFunding in €
Fundacion Para La Investigacion Biomedica Hospital Infantil Universitario Nino Jesus110 812
Fundación Para La Investigación E Innovación Biosanitaria De Atención Primaria63 563
 
Total Cost5 948 908